MISCLASSIFICATION OF RACE IN CARDIOVASCULAR DISEASE MORTALITY DATA
نویسندگان
چکیده
منابع مشابه
Bayesian Adjustment for Misclassification in Mortality Data
and [ ] 2 12 22 2 , , ..., r y y y y ′ = where r is the covariate pattern, 1 y is the exact cause of death and 2 y is the misclassified group in which the cause of death in the first group was incorrectly labeled, and 1 1 ~ ( ) i i y Poisson Pμ and 2 2 ~ ( ) i i y Poisson Pμ in which i μ is the observed rate of death mortality for the covariate pattern in Stamey et al. [1] approach, there is a ...
متن کاملsecuritization of mortality risks in life annuities
insurers have in the past few decades faced longevity risks - the risk that annuitants survive more than expected - and therefore need a new approach to manage this new risk. in this dissertation we survey methods that hedge longevity risks. these methods use securitization to manage risk, so using modern financial and insurance pricing models, especially wang transform and actuarial concepts, ...
15 صفحه اولImpact of misclassification on measures of cardiovascular disease mortality in the Islamic Republic of Iran: a cross-sectional study.
OBJECTIVE To assess the extent and pattern of misclassification of death from non-specific diagnoses emanating from the Iranian death registration system, and to correct the data for health policy and planning. METHODS Detailed medical records for 1426 hospital deaths classified to seven ill-defined or vague causes of death were reviewed by trained physicians, who then completed standard deat...
متن کاملThe role of microRNAs in cardiovascular disease
Cardiovascular disease has become the main factor of death and birth defects in the world. There are some therapeutic structures and drugs for curative and palliative therapy of the disease, but to the aim of accessing reliable therapy or to postpone onset of disease, especially for individuals with heritable coronary artery disease in their pedigree Genetic engineering technologies are making...
متن کاملCell Therapy in Cardiovascular Disease
Recently, cell therapy has sparked a revolution in ischemic heart disease that will in the future help clinicians to cure patients. Earlier investigations in animal models and clinical trials have suggested that positive paracrine effects such as neoangiogenesis and anti-apoptotic can improve myocardial function. In this regard the Royan cell therapy center designed a few trials in collaborat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Public Health
سال: 2005
ISSN: 0090-0036,1541-0048
DOI: 10.2105/ajph.2005.072215